Public Policy News

For more  information on how your organization can support our public policy efforts or how to develop an employee advocacy program, please contact John Slotman, BioNJ Vice President, Government Affairs, at


March 4 Issue

  • Rare Disease Day in Trenton Recap
  • Governor Murphy Unveils Budget
  • N.J.’s Innovation Evergreen Fund: Attracting Investments Today for Tomorrow’s Cures
  • Coronavirus Concerns Reach Capitol Hill

February 19 Issue

  • Senate President Sweeney Addresses BioNJ Annual Dinner Meeting and Innovation Celebration
  • Senate Special Committee Releases Incentives Report
  • Federal Budget Proposal Unveiled

January 22 Issue

  • Out-of-Pocket Legislation Signed into Law
  • Murphy Delivers State of the State
  • Lame Duck Session Concludes, Legislature Reorganizes
  • Governor Murphy: Opioid Deaths Decline
  • Task Force Releases Incentives Report
  • Smith Named to Lead Innovation Center


Alert: Dr. Stephen Hahn Confirmed as FDA Commissioner

Alert: House Passes H.R. 3

December 11 Issue

  • Drug Pricing Update: Awaiting House Vote, CBO Analysis Expected, CEA Estimate Unveiled
  • Trump Administration Releases Transparency Proposal
  • National Health Expenditure Data: Drug Prices Decline
  • Lame Duck Update
  • Assemblyman Benson Addresses BioNJ, Caregivers of NJ Event

November 12 Issue

  • Drug Pricing Update: House Vote Delayed Again
  • BioNJ Submits Comments on IRS Section 382 Proposal
  • Trump Nominates Stephen Hahn to Lead FDA
  • Election Update

October 30 Issue

  • Drug Pricing Update
  • BioNJ Submits Comments on Bioeconomy RFI
  • Assemblymen Schaer and Calabrese Visit BioNJ Member Cancer Genetics
  • Treasury Releases $114 Million of Held Funding

October 24 – Alert

  • HR 3 — We Need Your Help — Take Action Today

October 17 Issue

  • Drug Pricing Update
  • President Trump Unveils Medicare Executive Order
  • Governor Murphy Holds Economic Development Roundtable
  • NJ First Lady Murphy, NJEDA Host Golden Seeds Session
  • NJCSIT Announces Return of SBIR/STTR Assistance

October 2 Issue

  • Speaker Pelosi Unveils Drug Pricing Proposal, Committee Consideration Begins
  • Ways and Means Releases International Drug Pricing Report
  • Senate Committee Analyzing Incentives Continues Work

September 19 – Alert

  •  Speaker Pelosi Releases Drug Pricing Plan

September 18 Issue

  • NJ Senate Meets, Senate Committee Continues Incentive Hearings
  • Congresswoman Mikie Sherill Visits Modern Meadow
  • Congress Returns, Drug Pricing Discussion Continues
  • White House Office Seeks Input on “Bioeconomy”

September 5 Issue

  • Tax Incentive Extension Vetoed, Discussion Ongoing
  • Gag Clause, Claw Back Bill Signed into Law
  • Florida Submits Reimportation Proposal

August 21 Issue

  • Governor Murphy Signed Innovation District Legislation
  • Importation Pathways Unveiled
  • CMS Finalizes CAR-T Coverage
  • GAO Report: Rebates Mostly Passed to Plans

August 7 Issue

  • BioNJ Unveils Value of Medical Innovation Primer
  • Senate Select Committee Holds First Hearing
  • Finance Committee Considers Drug Pricing Legislation
  • President, Congressional Leadership Cut Budget Deal, Head Home for August District Work Period

July 10 Issue

  • Governor Murphy Approves State Health Exchange
  • Judge Blocks HHS DTC Rule
  • CMS Approves Louisiana State Plan Amendment

July 1 – Alert

June 27 – Alert

June 26 Issue

June 12 Issue

May 29 Issue

May 15 Issue

May 6, 2019

April 17, 2019

April 3, 2019

March 26, 2019

March 20, 2019

March 6, 2019

February 20, 2019

February 6, 2019